期刊文献+

TCRVβ7.1基因转染对肝癌细胞刺激的外周血单个核细胞ERK信号通路和IFN-γ表达的影响 被引量:1

TCRVβ7.1 transfection activates signal protein ERK and insreases IFN-γ expression in PBMCs
下载PDF
导出
摘要 目的:研究肝癌特异性识别基因TCRVβ7.1表达重组体转染外周血单个核细胞(PBMCs)后对T细胞细胞因子表达的影响和信号通路的激活作用。方法:以肝癌特异性T细胞受体Vβ7.1转染PBMCs,流式细胞仪检测TCRVβ7.1表达量;Western blotting检测ERK1/2表达量及磷酸化水平(p-ERK)的改变;用ELISA法检测白细胞介素-4(IL-4)、γ-干扰素(IFN-γ)的表达量。结果:TCRVβ7.1基因转染健康人PBMCs并得到有效表达,转染TCRVβ7.1基因的PBMCs与肝癌细胞共培养后ERK蛋白磷酸化水平明显高于未转染组(P<0.01)。p-ERK1/2水平与T细胞激活有关。ELISA结果表明,转染PBMCs细胞与肝癌细胞共培养后,IFN-γ水平明显高于未转染组,而IL-4无明显改变。结论:TCRVβ7.1转染PBMCs与肝癌细胞共培养后,ERK信号通路被激活,IFN-γ表达增高。 AIM : To investigate the effect of tumor - specific T cell receptor (TCR) gene transfection on production of cytokine and signaling activation in T cells. METHODS: TCRVβ7. 1 gene was transferred into peripheral blood mononuclear cells (PBMCs) obtained from healthy adults, and the expression of Vβ7. 1 was detected by flow cytometry before and after transfection. The total quantities of protein and phosphorylation of ERK1/2 were detected by Western blotting. The expressions of IL - 4 and IFN - γ were detected by ELISA. RESULTS : The results of flow cytometry showed that TCRVβ7. 1 protein was efficiently expressed after transfecfion. The phosphorylation level of ERK increased significantly in TCRVβ7. 1 - modified PBMCs, and was related with the activation of T cells. The expression of IFN - γ was significantly higher in TCR -transfected cells than that in non -transfected cells. The expression of IL -4, however, has no distinct difference between groups. CONCLUSION: The transfection of TCRVβ7. 1 induces phosphorylation of ERK1/2 and production of IFN - γ, and activates T lymphocytes.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第8期1505-1508,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30572124) 广东省自然科学基金资助项目(No.034046) 广东省科技计划资助项目(No.2004B31201001)
关键词 基因 TCRVβ7.1 基因转染 细胞外信号调节激酶类 干扰素Γ Genes, TCRVβ7.1 Gene transfection Extracellular signal - regulated kinases Interferon - gamma
  • 相关文献

参考文献4

二级参考文献43

  • 1黄翠萍,张珍祥,徐永健.p38丝裂原活化蛋白激酶信号传递通路和支气管哮喘气道炎症[J].国外医学(呼吸系统分册),2005,25(9):656-658. 被引量:12
  • 2黄翠萍,杨和平,张珍祥,徐永健.p38蛋白激酶对支气管哮喘大鼠Th2类细胞因子表达的调控[J].中国病理生理杂志,2006,22(2):311-313. 被引量:18
  • 3刘莎,符州.黄芪的免疫调节作用及其临床应用[J].国际中医中药杂志,2006,28(4):203-206. 被引量:75
  • 4Kay AB. Allergy and allergic diseases. Part Ⅰ[ J]. N Eng J Med,2001,344( 1 ) :30 -37.
  • 5Stirling RG, Chung KF. New immunological approaches and cytokine targets in asthma and allergy [ J ]. Eur Respir J, 2000,16(6):1158 -1174.
  • 6Herlaar E, Brown Z. p38 MAPK signaling cascades in inflammatory disease [ J ]. Mol Med Today, 1999, 5 (10) : 439 - 447.
  • 7Yiamouyiannis CA, Schramm CM, Puddington L, et al. Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model[J]. Am J Pathol, 1999, 154(6) :1911 - 1921.
  • 8Dechene L. Thl/Th2 immune response [ J ]. J Allergy Clin Immunol, 2002,110(3) :539 - 540.
  • 9Widmman C, Gibson S, Jarpe MB, et al. Mitogen -activated protein kinase: conservation of a three - kinase module from yeast to human[J]. Physiol Rev, 1999,79( 1 ) : 143 - 180.
  • 10Ishizuka T, Okajima F, Ishiwara M, et al. Sensitized mast cells migrate toward antigen: a response regulated by p38 mitogen- activated protein kinase and Rho- associated coiled - coil - forming protein kinase [ J ]. J Immunol, 2001, 167 (4) :2298 -2304.

共引文献42

同被引文献23

  • 1Rosenberg SA, Restifo NP, Yang JC, et al. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer, 2008, 8(4):299-308.
  • 2Schumacher TN, Restifo NR Adoptive T cell therapy of cancer. Curr Opin Immunol, 2009, 21 (2): 187-189.
  • 3Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol, 2012, 12(4): 269-281.
  • 4Boon T, Coulie PC, Van den Eynde BJ, et al. Human T cell responses against melanoma. Annu Rev Immunol, 2006, 24:175-208.
  • 5Murphy A, Westwood JA, Teng MW, et al. Gene modification strategies to induce tumor immunity. Immunity, 2005, 22(4):403-414.
  • 6Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science, 2006, 314(5796):126-129.
  • 7Dudley ME, Wunderlich J, Nishimura MI, et al. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother, 2001, 24(4):363-373.
  • 8Yee C, Thompson JA, Byrd D, et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred cells. Proc Natl Acad Sci U S A, 2002, 99(24): 16168-16173.
  • 9Boyman O, Letoumeau S, Krieg C, et al. Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol, 2009,39(8): 2088-2094.
  • 10Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol, 2000, 164(5):2338-2346.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部